The determination of the dose to organs from diagnostic x rays has become important because of reports of radiation injury to patients from fluoroscopically guided interventional procedures. We have modified a convolution/superposition-based treatment planning system to compute the dose distribution for kilovoltage beams. We computed lung doses using this system and compared them to those calculated using the CDI3 organ dose calculation program. We also computed average lung doses from a simulated radiofrequency ablation procedure and compared our results to published doses for a similar procedure. Doses calculated using this system were an average of 20% lower for AP beams and 7% higher for PA beams than those obtained using CDI3. The ratio of the average dose to the lungs to the skin dose from the simulated ablation procedure ranged from 25% higher to 15% lower than that determined by other authors. Our results show that a treatment planning system designed for use in the megavoltage energy range can be used for calculating organ doses in the diagnostic energy range. Our doses compare well with those previously reported. Differences are partly due to variations in experimental techniques. Using a three-dimensional ͑3-D͒ treatment planning system to calculate dose also allows us to generate dose volume histograms ͑DVH͒ and compute normal tissue complication probabilities ͑NTCP͒ for diagnostic procedures.
I. INTRODUCTION
In recent years, there have been several investigations dealing with the dose to skin and internal organs as a result of fluoroscopically guided procedures in radiology and cardiology. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Various methods, including direct and indirect measurements, calculations, and Monte Carlo simulations have been employed to estimate the dose to skin and other sensitive organs. The results obtained by these methods are different, sometimes by substantial amounts.
In the present investigation, we used the Pinnacle treatment planning system ͑ADAC Laboratories, Milpitas, CA͒ to determine the dose distribution within two phantoms. We first determined the dose distribution in a phantom and compared our results to those of the CDI3 organ dose computation program. The phantom used here is described in the following section. We then computed the dose distribution from an interventional cardiac procedure within the Rando phantom and compared our results to previous investigations. The Pinnacle system was previously modified to enable it to calculate the dose in the diagnostic energy range by generating photon energy deposition kernels in the range of 20-110 keV. 11 The system's accuracy was further tested in the phantom.
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II. MATERIALS AND METHODS
A. Comparison to CDI3 program
The CDI3 computer program is designed to calculate the absorbed dose to tissues of patients as a result of radiographic/fluoroscopic examinations. 13 It estimates the tissue doses from beam parameters entered by the user and a table of tissue-air ratios generated previously by a Monte Carlo technique. This program and the data tables generated using it have been extensively used to estimate tissue doses from diagnostic procedures. 5, 9, [14] [15] [16] The CDI3 uses a mathematical phantom based on the adult human phantom described in MIRD 5. 17 The phantom has been modified further in subsequent investigations but the version of the phantom used by CDI3 is the one described in FDA publication 76-8030. 14, 18 Using the mathematical descriptions in this FDA report, the phantom was graphically reconstructed and entered into the Pinnacle treatment planning computer. Since our focus was on the lung dose, only the external outline of the trunk portion of the phantom along with the lungs and spine were entered into the computer. The lungs, spine, and the rest of the phantom were assigned the densities of 0.3, 1.5, and 1.0 g/cm 3 , respectively, to match the densities used in the CDI3 program. The resultant phantom in Pinnacle agrees well with the specifications given for the actual phantom. The total lung volume for the reconstructed phantom in Pinnacle is 3319 cm 3 vs 3378 cm 3 for the phantom used in CDI3. 14 The CDI3 program was used to calculate the lung doses from 50 fluoroscopic beams. These beams ranged in energy from 60 to 120 kVp and in field size ͑defined at 50 cm SSD͒ from 8.5ϫ8.5 to 15.0ϫ15.0 cm 2 . The beams were directed at different positions on the phantom in the chest and abdomen areas with AP, PA, or lateral orientations. SSDs of 50, 55, and 60 cm were used. Average lung doses were obtained for the same beams using the Pinnacle system.
The CDI3 program calculates the organ doses based on a given skin entrance exposure, which in this case was set to 1000 mR. To reproduce an equivalent beam fluence in Pinnacle, the entrance skin exposure of 1000 mR was converted to absorbed dose by multiplying the exposure by the appropriate backscatter factor ͑BSF͒ and f factor. This value of skin dose was then converted to the dose value at 1 cm depth by multiplying it with the appropriate percentage depth dose ͑PDD͒ taken from the tables generated during beam measurements. 19 In the case of SSDs other than 50 cm, the Mayneord F factor was employed to correct the PDD value to that at the extended SSD. The dose at 1 cm depth was thus determined for each beam. This dose value was then used to generate equivalent beams in Pinnacle by adjusting the beam prescription ͑time/monitor unit setting͒ to get the desired dose value at 1 cm depth for each beam. The average lung dose was then determined from Pinnacle. The BSF and f factor values were obtained from ''The British Journal of Radiology Supplement 25,'' 20 and ''The Physics of Radiology'', 21 respectively.
B. Comparison to other investigations
In order to simulate a typical radiofrequency ͑rf͒ catheter ablation procedure, three beams ͑100 kVp, 3.2 mm A1 HVL, 2-3 mA͒ were directed on the Rando phantom in the thorax region. The beam orientations were at PA, RPO, and LPO directions. The fields were square in shape, centered on the heart, and their size was adjusted to just cover the heart volume ͑Table I͒. The beam orientations/angles were chosen based on data gathered by Geise et al. 22 CT scans of the Rando phantom were imported into Pinnacle and external contouring was performed on the scans. A number of internal contours were also drawn, including the lungs, sternum, and the heart. Since the Rando phantom does not contain a heart, the location of the heart was drawn on the CT slices by a radiologist. The beams were weighed differently at different trials and it was observed that changing the beam weight had little effect on the average lung dose as long as the total time divided between the three beams remained constant ͑Table II͒. Thus, an average value for each organ dose was obtained from ten different trials. The total time for the test procedure was set to 60 min. The tabletop transmission was measured and found to be approximately 90% for the 100 kVp beam. This was taken into account by adding a 1 cm water-equivalent bolus to the posterior surface of the phantom in Pinnacle.
III. RESULTS
A. Comparison to CDI3 program
The results of comparisons between Pinnacle-computed values and those obtained using the CDI3 program are tabulated in Table III . As seen in the table, there is an average percentage difference of Ϫ6.8% between the two results. Further analysis shows that the average Pinnacle-calculated lung doses are about 20% lower than those obtained from the CDI3 program for the AP projections and about 7% higher for the PA ones. The calculations were performed several times to verify this difference. The reason for this consistent discrepancy is unknown. However, we can say with certainty that this is not due to a systemic error in our methods. 
B. Comparison to other investigations
The dose distribution from the three-field combination mentioned above is illustrated in Fig. 1 . As stated previously, changing the weighting of the three beams, but keeping the total time constant, has little effect on the lung dose. As expected, the highest dose was delivered to the skin and superficial tissues. The average lung dose from this simulated procedure was determined using Pinnacle because the lungs are among the sensitive organs in these procedures, which would receive a significant dose. Based on this threefield beam configuration, the average lung dose from 60 min of fluoroscopy using the configuration shown in Fig. 1 is about 0.26 Gy. The approximate maximum central axis skin dose for all the beams in a plan varies from 1.3 to 3.1 Gy depending on beam configuration. For example, for a plan with beam weighting of PA:50%, RPO:20%, LPO:30%, the maximum skin dose is approximately 1.8 Gy. For a plan with 100% beam weight on PA field, the maximum skin dose is approximately 3.1 Gy.
IV. DISCUSSION
A number of investigators have reported skin and lung doses for rf catheter ablation of the heart wall. Rosenthal et al. 1 calculated the entrance skin dose based on technique factors such as mA, backscatter factor ͑BSF͒, source-skin distance ͑SSD͒, and fluoroscopy time. They assumed a constant SSD and kVp and that exposure is confined to the same area of the skin. The average fluoroscopy time for their patient population is 53 min and the mean entrance radiation dose on the skin is 1.4 Gy for adults. Based on data available in a FDA handbook, 23 the lung dose was estimated to be 0.12 Gy for males and 0.08 Gy for females. The above data is comparable to that of Park et al. 2 They measured the mean entrance exposure rate using an ion chamber on a phantom for three common projections. They then used the fluoroscopy time for each patient to calculate the skin dose. They also assumed that exposure is confined to the same area of skin. Their average fluoroscopy time is 46.5 min and their computed skin dose is 0.93 Gy. They do not report a lung dose.
Calkins et al. 3 used six TLDs on each patient to measure skin dose. Their reported average time is 44 min. They report the median radiation skin entrance dose to be 0.073 Gy and estimate the dose to one-third of the lung to be 0.075 Gy. Lindsay et al. 4 measured radiation exposure with a method identical to Park, using the same phantom and chamber/ electrometer and for the three common projections with a SSD of 61 cm. The entrance exposure rate is 1.6-2.2 R/min, depending on projection with an average of 1.93 R/min, identical to Park. The mean fluoroscopy time for their patient population is 50 min. They estimated the lung dose for 55 min of fluoroscopy to be 0.069 Gy using the data in the CRC handbook. 15 In a recent study, Kovoor et al. 5 used a TLD array for dose measurements. The study was limited to nine female patients with an average fluoroscopy time of 94 min. The highest measured skin dose per 60 min of fluoroscopy is 0.12 Gy and the lung dose is estimated at 0.03 Gy calculated using the CDI3 organ dose calculation program. 13 A comparison of our results with previous investigations reveals the following: One of the weighting trials we attempted is identical to Rosenthal's assumption, in which only a PA beam was used. In this instance, for 60 min of fluoroscopy, our skin dose is about 3.1 Gy, which is 1.7 times that reported by Rosenthal for male patients. Our lung dose in this instance is 0.26 Gy, which is 2.1 times the 0.12 Gy reported by Rosenthal for male patients. This yields a lung/skin ratio of 6.7% ͑Rosenthal͒ versus 8.4% ͑this investigation͒ that is comparable considering the many differences between these two studies.
Our lung/skin dose ratio for the average of all the three field plans is about 22%, which is somewhat lower than the 26% reported by Kovoor, 5 who reported a skin dose of 0.12 Gy and a lung dose of 0.03 Gy for female patients. Although his skin dose is much less than what we, and others, have estimated, his lung/skin dose ratio is comparable to ours considering the differences between the studies. Other investigators 3, 4 have reported a lung dose of about 0.07 Gy, which is considerably less than ours, without a clear indication of the skin dose. When comparing all these studies, one should note that there are wide variations in beam technique factors, methods of measurements, and patient population/ gender and/or phantoms. The results of the above comparisons and specifics of each study are summarized in Table IV .
The above evaluations of the Pinnacle dose calculation algorithm demonstrate that this system can be used with sufficient accuracy to determine the dose distribution within the body as well as the average dose to specific organs from diagnostic quality x rays. A limitation to this system is its inability to compute the dose in and around bones, which can be corrected for by modifying the CT number-to-density table. 12 Other than this limitation, it can be concluded that using this system to estimate organ doses is a comparable method to those previously employed.
Another capability of this treatment planing system is the ability to calculate dose volume histograms ͑DVH͒. The DVH gives a more precise picture of the dose distribution within the tissue or organ of interest and is often used to estimate the probability of complications in normal tissue receiving radiation in therapeutic radiology. This probability, called normal tissue complication probability ͑NTCP͒, is a biological index that makes use of the tolerance dose data for a given tissue to predict the probability of complications as a result of irradiation. Both DVH and NTCP have been used in therapeutic radiology but have not been introduced into diagnostic radiology.
The ability to generate dose distributions from diagnostic quality beams using Pinnacle provides us with the opportunity to extend the concepts of DVH and NTCP into the diagnostic radiology realm. At present, however, there is limited utility for these in diagnostic radiology due to the relatively low doses and rare probability of complications from them. In addition, use of the NTCP in diagnostic radiology raises the question of its applicability in the diagnostic energy range.
Current tolerance doses used for NTCP calculations are based upon clinical observations of complications in patients undergoing radiation therapy treatment. 24 Thus, they are based on fractionated irradiation of tissue. In diagnostic radiology, the tissue is often irradiated in one fraction. Lyman 25 has proposed a method by which the change in fractionation could be taken into account by modifying the formula describing the tolerance dose for partial volume irradiation. Using this approach, the tolerance dose values can be changed according to the fractionation scheme from several fractions to one or two fractions in the case of diagnostic procedures. The NTCP can then be determined using the new tolerance dose values.
Even though the tolerance doses used in NTCP determination are based upon data obtained from megavoltage radiation therapy treatments, they should still be largely applicable to diagnostic x rays. In many respects, these data are as applicable as the data used for risk estimates in BEIR V 26 and ICRP 60 27 reports, which have been used in several investigations for risk estimate assessment in the diagnostic energy range. 1, [3] [4] [5] The data used in BEIR V and ICRP 60 come from diagnostic and therapeutic x-ray exposure studies as well as the atomic bomb survivor data. But, as stressed in ICRP 60, both BEIR V and ICRP 60 have selected the A-bomb survivors as the most complete set of information on which to base quantitative risk estimates. It should be kept in mind that atomic bomb survivors were exposed to mixed fields of x, gamma, and particulate radiation, each with is own quality factor. Therefore, considering the caveat for risk estimation in BEIR V or ICRP 60, the NTCPs based on fractionated radiation in the therapeutic energy range should be quite applicable to the diagnostic energy range. 
V. CONCLUSIONS
This work has shown that it is possible to use a treatment planning system to determine dose distributions for diagnostic beams provided that the necessary beam data is available. The comparisons we have made with the organ dose calculation program ͑CDI3͒ show that, in general, our results are comparable with those obtained using this program. Our comparisons with those investigations that used actual patient data show larger variations partially due to the differences among the experimental settings, the lack of complete information on techniques used, variations in investigation techniques and tools, and limitations of each system of dose calculations.
An advantage of using the treatment planning system for these types of calculations is that once the energy deposition kernels and the necessary beam data are entered into the computer, no further measurements are needed except for recording of information such as beam kVp/mA, fluoroscopy time, and beam orientation͑s͒ for the procedure. In addition, modeling a beam on Pinnacle does not necessarily mean a complete beam dataset is required. The only required piece of information is the dose rate value for the desired beams for each kVp/mA setting. All other beam data ͑depth dose and cross plots͒ are only used to match the measured and modeled beam. Therefore, a limited set of beam data would be enough for verification of modeled beams if the various Pinnacle-specific factors required for modeling of similar beams are known.
Finally, an added advantage of this system is the ability to obtain the DVH and determine the NTCP for diagnostic procedures. This data can be used to estimate possible cancer induction from these types of procedures. 
